Expert Tips for Tackling Atopic Dermatitis in Pediatric Practice

Slides:



Advertisements
Similar presentations
Atopic Dermatitis: Disease Impact and Therapy
Advertisements

Moderate-to-Severe Asthma Management
New Psoriasis Treatments
Psoriatic Arthritis.
Please note this program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States.
Improving Survival in Glioblastoma Multiforme
Advances in Managing Inhibitors in Patients With Hemophilia A
Essential Updates in Atopic Dermatitis:
Exploring the Spectrum of Excessive Daytime Sleepiness
Pseudomonas Lung Infections in Cystic Fibrosis
Dual Antiretroviral Therapy
Progression After Cancer Immunotherapy in Advanced NSCLC
Understanding the Many Faces of Pseudobulbar Affect
Ask the Onychomycosis Expert, Part 2
Ask the Onychomycosis Expert, Part 1
Standards of Care in Duchenne Muscular Dystrophy: A 2018 Update
Improving Acne Outcomes
Atopic Dermatitis Treatment Landscape
Case Challenges in Chronic Migraine
Updates in Management of Atopic Dermatitis From Real Patient Cases
Atopic Dermatitis Treatment Landscape
Before and After: Patient Cases in Onychomycosis
Program Goals. Program Goals What is Atopic Dermatitis?
Issues in the Management of Hemophilia: A Best Practice Series
Treating Transplant-Ineligible Patients With Multiple Myeloma
Assessing Newer Treatment Approaches for Multiply Relapsed Multiple Myeloma.
Therapeutic Strategies in the Management of Mild-to-Moderate Atopic Dermatitis.
The Resurgence of Topical Treatments Across a Spectrum of Psoriasis
Chronic Idiopathic Urticaria
The Nurse View.
Addressing Disease Burden in Asthma
Asthma and Atopic Comorbidities
Translating Atopic Dermatitis
Improving Outcomes in OSA
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Hyperhidrosis Is Burdensome!
Gene Therapy: Past, Present, and Future
Emerging Atopic Dermatitis Treatments:
Tackling Atopic Dermatitis
Expert Debate in MDD.
Ask the Experts.
Optimizing Frontline Care for Older Patients With Multiple Myeloma
New Recommendations on How to Stage Hidradenitis Suppurativa
When Is Biologic Therapy Appropriate for HS?
The Evolving Treatment Landscape in Atopic Dermatitis
Current and Emerging Strategies for Management of Moderate-to-Severe Atopic Dermatitis.
Expert Perspectives on the Clinical Use of Immune Reconstitution vs Escalation Therapy for MS.
Background. Advancing the Care of Patients With Moderate to Severe Atopic Dermatitis: A Case-Based Discussion.
Understanding and Addressing the Needs of Patients With AD
Advances in Severe Asthma Management
Guide to Atopic Dermatitis
Atopic Dermatitis in the Pediatric Practice
Clinical Pearls on Hot Topics in MS
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Managing Your Patient’s Maintenance Therapy for Multiple Myeloma
EGPA.
The Burden of Psoriasis:
Patient Questions and Expert Answers in Psoriasis:
Expert Perspectives in the Recognition and Management of Lennox-Gastaut Syndrome.
Patient and Clinician Perspectives on Preventive Therapy for Migraine
Update on the Management of Atopic Dermatitis
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the United States, and data.
Improving Adherence to Antiplatelet Therapy After an ACS Event
The Nurse View: Spotlight on Immune Checkpoint Inhibitors in Advanced Lung Cancer.
This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US, and data that were.
Immune Checkpoint Inhibitors in Lung Cancer
Ask the Psoriasis Expert
The Real Burden of Rosacea
Navigating the Journey
Presentation transcript:

Expert Tips for Tackling Atopic Dermatitis in Pediatric Practice

This program will include a discussion of off-label treatment and investigational agents not approved by the FDA for use in the US.

AD in Children

Case 1 Harry

Differential Diagnoses of AD in Pediatric Patients

The Atopic March

Prevalence of Atopic Comorbidities in Children With AD

Atopy in Children

Basic Skin Care

Tips From the Experts

Written Action Plan

Case 2 Jasmine

TCS First-Line Treatment

Steroid Phobia Is a Common Issue

Overcoming Steroid Phobia

Developing a Proactive Regimen

TCIs

Topical Crisaborole Ointment

ADHD Prevalence Is Higher in Children With AD

Dilute Bleach Baths?

Jasmine Case Conclusion

Case 3 Neena

AD Affects Multiple Domains

Adherence to Treatment

The Stigma of AD

Psychosocial Burden of AD

Psychosocial Burden of AD (cont)

The Itch That Needs to Be Scratched

Antihistamines

Systemic Therapy?

Abbreviations